These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2142880)
1. Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy. Kawai H; Adachi K; Kimura C; Nishiuchi T; Yamasaki Y; Tsutsui Y; Saito S Arch Neurol; 1990 Aug; 47(8):900-4. PubMed ID: 2142880 [TBL] [Abstract][Full Text] [Related]
2. [Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy]. Kimura C; Kawai H; Adachi K; Nishiuchi T; Saito S Rinsho Shinkeigaku; 1989 Mar; 29(3):290-5. PubMed ID: 2526701 [TBL] [Abstract][Full Text] [Related]
3. [Alteration of atrial natriuretic peptide in progressive muscular dystrophy with congestive heart failure]. Miyai I; Kang J; Nozaki S; Matsumura T Rinsho Shinkeigaku; 1992 Jun; 32(6):588-92. PubMed ID: 1424336 [TBL] [Abstract][Full Text] [Related]
4. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy]. Kashiwagi S; Akaike M; Kawai H; Adachi K; Saito S Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy. Yanagisawa A; Yokota N; Miyagawa M; Kawamura J; Ishihara T; Aoyagi T; Ishikawa K Am Heart J; 1990 Nov; 120(5):1154-8. PubMed ID: 2146865 [TBL] [Abstract][Full Text] [Related]
6. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996 [TBL] [Abstract][Full Text] [Related]
7. Cardioprotection for Duchenne's muscular dystrophy. Ishikawa Y; Bach JR; Minami R Am Heart J; 1999 May; 137(5):895-902. PubMed ID: 10220639 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy. Adachi K; Kawai H; Saito M; Naruo T; Kimura C; Mine H; Inui T; Kashiwagi S; Akaike M Intern Med; 1997 Jul; 36(7):497-500. PubMed ID: 9240500 [TBL] [Abstract][Full Text] [Related]
9. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293 [TBL] [Abstract][Full Text] [Related]
10. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. Tsutamoto T; Kanamori T; Wada A; Kinoshita M J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959 [TBL] [Abstract][Full Text] [Related]
11. Relationship of natriuretic peptide and transthoracic echocardiographic findings in 135 subjects with muscular dystrophy. Kawakubo M; Funabashi N; Takahashi M; Sueishi M; Motoyoshi Y; Mikata T; Uchida I; Asakawa T; Takahashi R; Takamatsu M; Matsuoka Y; Minegishi M; Naga H; Yajima R; Kataoka A; Lee K; Komuro I Int J Cardiol; 2010 Dec; 145(3):506-14. PubMed ID: 20061036 [No Abstract] [Full Text] [Related]
12. Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy. Kiessling WR; Beckmann R Klin Wochenschr; 1981 Apr; 59(7):347-8. PubMed ID: 7241957 [TBL] [Abstract][Full Text] [Related]
13. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW J Am Coll Cardiol; 1996 Mar; 27(3):720-7. PubMed ID: 8606288 [TBL] [Abstract][Full Text] [Related]
14. The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier. Konagaya M; Takayanagi T; Konagaya Y; Sobue I J Neurol Sci; 1982 Sep; 55(3):259-65. PubMed ID: 6890096 [TBL] [Abstract][Full Text] [Related]
15. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Anderson JV; Woodruff PW; Bloom SR Br Heart J; 1988 Feb; 59(2):207-11. PubMed ID: 2963658 [TBL] [Abstract][Full Text] [Related]
16. Dual natriuretic peptide system in experimental heart failure. Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW J Am Coll Cardiol; 1993 Sep; 22(3):891-8. PubMed ID: 8354829 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation. Van Den Berg MP; Crijns HJ; Van Veldhuisen DJ; Van Gelder IC; De Kam PJ; Lie KI Am Heart J; 1998 Feb; 135(2 Pt 1):242-4. PubMed ID: 9489971 [TBL] [Abstract][Full Text] [Related]
18. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase? Kiessling WR; Beckmann R Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564 [No Abstract] [Full Text] [Related]
19. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907 [TBL] [Abstract][Full Text] [Related]
20. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Meleagros L; Gibbs JS; Ghatei MA; Bloom SR Br Heart J; 1988 Jul; 60(1):39-44. PubMed ID: 2970269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]